德罗纳达龙化 (DH) 诱导胰腺癌细胞死亡,通过触发mtDNA介导的烧灭细胞
Ming-Qiao Li1,2,3,4, Yu-Qi He1,2,3,4, Meng-Ni Zhang1,2,3,4
1Department of Gastroenterology, the First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Cell death & disease
|October 2, 2024
概括
德罗纳达龙化诱导胰腺癌细胞的编程细胞死亡 (pyroptosis),减缓瘤的生长. 这种抗失常药物显示出治疗胰腺管道腺癌 (PDAC) 的潜力.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰腺癌由于高死亡率和有限的治疗选择而构成重大全球健康挑战.
- 诱导炎症性细胞死亡的一种形式 - - 炎症性细胞死亡 - - 已经成为阻止胰腺管道腺癌 (PDAC) 进展的有希望的策略.
研究的目的:
- 为了研究Dronedarone化 (DH) 的潜力,一种抗心律失常药物,作为胰腺癌治疗中的 pyroptosis 诱导剂.
- 阐明DH诱导热的机制,并评估其在PDAC临床前模型中的有效性.
主要方法:
- 利用 PANC-1 细胞来评估 DH 诱导的细胞死亡和热的标记物.
- 研究了DH对线粒体压力和DNA泄漏的影响.
- 采用热灭菌抑制剂和GSDMD沉默来确认热灭菌路径.
- 在胰腺癌的小鼠模型中评估了DH的抗癌作用.
主要成果:
- DH治疗导致了PANC-1细胞的剂量和时间依赖的细胞死亡,特别是通过GSDMD-依赖的灭.
- DH增加了线粒体压力,诱导了线粒体DNA (mtDNA) 释放,激活了STING-cGAS通路.
- 在体内研究表明,DH显著抑制了小鼠的胰腺瘤发育.
结论:
- 德罗纳达龙化有效地触发了胰腺癌细胞中的GSDMD依赖性热.
- DH的机制涉及线粒体应激和随后的STING-cGAS通路的激活.
- DH具有显著的抗PDAC生长潜力,需要进一步研究作为治疗剂.
更多相关视频
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.6K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
01:46Electron Transport Chain: Complex I and II
12.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K